調査レポート | • レポートコード：QYR2104Z3493 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、肺がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、化学療法、放射線療法、光線力学療法、レーザー療法）、用途別市場規模（病院・クリニック、がん研究センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・肺がんの市場動向 ・企業の競争状況、市場シェア ・肺がんの種類別市場規模（手術、化学療法、放射線療法、光線力学療法、レーザー療法） ・肺がんの用途別市場規模（病院・クリニック、がん研究センター、その他） ・肺がんの北米市場規模2016-2027（アメリカ、カナダ） ・肺がんのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・肺がんのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肺がんの中南米市場規模2016-2027（メキシコ、ブラジル） ・肺がんの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Novartis、Pfizer、Merck、Bristol-Myers Squibb、Eli Lilly And Company、Sanof） ・結論 |
Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as primary lung cancers, are carcinomas. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains.
Lung cancer is the most common cause of cancer-related death in men and second most common in women after breast cancer. The most common age at diagnosis is 70 years. Overall, 17.4% of people in the United States diagnosed with lung cancer survive five years after the diagnosis, while outcomes on average are worse in the developing world.
Market Analysis and Insights: Global Lung Cancer Market
The global Lung Cancer market size is projected to reach US$ 31210 million by 2026, from US$ 18520 million in 2019, at a CAGR of 7.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lung Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lung Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lung Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lung Cancer market.
Global Lung Cancer Scope and Market Size
Lung Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Surgery
Chemotherapy
Radiotherapy
Photodynamic Therapy
Laser Therapy
Segment by Application
Hospital & Clinics
Cancer Research Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Novartis
Pfizer
Merck
Bristol-Myers Squibb
Eli Lilly And Company
Sanof
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Chemotherapy
1.2.4 Radiotherapy
1.2.5 Photodynamic Therapy
1.2.6 Laser Therapy
1.3 Market by Application
1.3.1 Global Lung Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital & Clinics
1.3.3 Cancer Research Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Market Perspective (2016-2027)
2.2 Lung Cancer Growth Trends by Regions
2.2.1 Lung Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lung Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Lung Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Lung Cancer Industry Dynamic
2.3.1 Lung Cancer Market Trends
2.3.2 Lung Cancer Market Drivers
2.3.3 Lung Cancer Market Challenges
2.3.4 Lung Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Players by Revenue
3.1.1 Global Top Lung Cancer Players by Revenue (2016-2021)
3.1.2 Global Lung Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Lung Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Revenue
3.4 Global Lung Cancer Market Concentration Ratio
3.4.1 Global Lung Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Revenue in 2020
3.5 Lung Cancer Key Players Head office and Area Served
3.6 Key Players Lung Cancer Product Solution and Service
3.7 Date of Enter into Lung Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Breakdown Data by Type
4.1 Global Lung Cancer Historic Market Size by Type (2016-2021)
4.2 Global Lung Cancer Forecasted Market Size by Type (2022-2027)
5 Lung Cancer Breakdown Data by Application
5.1 Global Lung Cancer Historic Market Size by Application (2016-2021)
5.2 Global Lung Cancer Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Lung Cancer Market Size (2016-2027)
6.2 North America Lung Cancer Market Size by Type
6.2.1 North America Lung Cancer Market Size by Type (2016-2021)
6.2.2 North America Lung Cancer Market Size by Type (2022-2027)
6.2.3 North America Lung Cancer Market Size by Type (2016-2027)
6.3 North America Lung Cancer Market Size by Application
6.3.1 North America Lung Cancer Market Size by Application (2016-2021)
6.3.2 North America Lung Cancer Market Size by Application (2022-2027)
6.3.3 North America Lung Cancer Market Size by Application (2016-2027)
6.4 North America Lung Cancer Market Size by Country
6.4.1 North America Lung Cancer Market Size by Country (2016-2021)
6.4.2 North America Lung Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Lung Cancer Market Size (2016-2027)
7.2 Europe Lung Cancer Market Size by Type
7.2.1 Europe Lung Cancer Market Size by Type (2016-2021)
7.2.2 Europe Lung Cancer Market Size by Type (2022-2027)
7.2.3 Europe Lung Cancer Market Size by Type (2016-2027)
7.3 Europe Lung Cancer Market Size by Application
7.3.1 Europe Lung Cancer Market Size by Application (2016-2021)
7.3.2 Europe Lung Cancer Market Size by Application (2022-2027)
7.3.3 Europe Lung Cancer Market Size by Application (2016-2027)
7.4 Europe Lung Cancer Market Size by Country
7.4.1 Europe Lung Cancer Market Size by Country (2016-2021)
7.4.2 Europe Lung Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Market Size (2016-2027)
8.2 Asia-Pacific Lung Cancer Market Size by Type
8.2.1 Asia-Pacific Lung Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lung Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lung Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Lung Cancer Market Size by Application
8.3.1 Asia-Pacific Lung Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lung Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lung Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Lung Cancer Market Size by Region
8.4.1 Asia-Pacific Lung Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lung Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Lung Cancer Market Size (2016-2027)
9.2 Latin America Lung Cancer Market Size by Type
9.2.1 Latin America Lung Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Lung Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Lung Cancer Market Size by Type (2016-2027)
9.3 Latin America Lung Cancer Market Size by Application
9.3.1 Latin America Lung Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Lung Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Lung Cancer Market Size by Application (2016-2027)
9.4 Latin America Lung Cancer Market Size by Country
9.4.1 Latin America Lung Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Lung Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Market Size (2016-2027)
10.2 Middle East & Africa Lung Cancer Market Size by Type
10.2.1 Middle East & Africa Lung Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lung Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lung Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Lung Cancer Market Size by Application
10.3.1 Middle East & Africa Lung Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lung Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lung Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Lung Cancer Market Size by Country
10.4.1 Middle East & Africa Lung Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lung Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Lung Cancer Introduction
11.1.4 Roche Revenue in Lung Cancer Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Lung Cancer Introduction
11.2.4 Novartis Revenue in Lung Cancer Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Lung Cancer Introduction
11.3.4 Pfizer Revenue in Lung Cancer Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Lung Cancer Introduction
11.4.4 Merck Revenue in Lung Cancer Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Lung Cancer Introduction
11.5.4 Bristol-Myers Squibb Revenue in Lung Cancer Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Eli Lilly And Company
11.6.1 Eli Lilly And Company Company Details
11.6.2 Eli Lilly And Company Business Overview
11.6.3 Eli Lilly And Company Lung Cancer Introduction
11.6.4 Eli Lilly And Company Revenue in Lung Cancer Business (2016-2021)
11.6.5 Eli Lilly And Company Recent Development
11.7 Sanof
11.7.1 Sanof Company Details
11.7.2 Sanof Business Overview
11.7.3 Sanof Lung Cancer Introduction
11.7.4 Sanof Revenue in Lung Cancer Business (2016-2021)
11.7.5 Sanof Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Lung Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiotherapy
Table 5. Key Players of Photodynamic Therapy
Table 6. Key Players of Laser Therapy
Table 7. Global Lung Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Lung Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Lung Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Lung Cancer Market Share by Regions (2016-2021)
Table 11. Global Lung Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Lung Cancer Market Share by Regions (2022-2027)
Table 13. Lung Cancer Market Trends
Table 14. Lung Cancer Market Drivers
Table 15. Lung Cancer Market Challenges
Table 16. Lung Cancer Market Restraints
Table 17. Global Lung Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Lung Cancer Market Share by Players (2016-2021)
Table 19. Global Top Lung Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer as of 2020)
Table 20. Ranking of Global Top Lung Cancer Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Lung Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Lung Cancer Product Solution and Service
Table 24. Date of Enter into Lung Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Lung Cancer Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Lung Cancer Revenue Market Share by Type (2016-2021)
Table 28. Global Lung Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Lung Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Lung Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Lung Cancer Revenue Market Share by Application (2016-2021)
Table 32. Global Lung Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Lung Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Lung Cancer Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Lung Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Lung Cancer Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Lung Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Lung Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Lung Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Lung Cancer Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Lung Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Lung Cancer Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Lung Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Lung Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Lung Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Lung Cancer Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Lung Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Lung Cancer Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Lung Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Lung Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Lung Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Lung Cancer Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Lung Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Lung Cancer Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Lung Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Lung Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Lung Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Lung Cancer Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Lung Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Lung Cancer Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Lung Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Lung Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Lung Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 64. Roche Company Details
Table 65. Roche Business Overview
Table 66. Roche Lung Cancer Product
Table 67. Roche Revenue in Lung Cancer Business (2016-2021) & (US$ Million)
Table 68. Roche Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Lung Cancer Product
Table 72. Novartis Revenue in Lung Cancer Business (2016-2021) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Lung Cancer Product
Table 77. Pfizer Revenue in Lung Cancer Business (2016-2021) & (US$ Million)
Table 78. Pfizer Recent Development
Table 79. Merck Company Details
Table 80. Merck Business Overview
Table 81. Merck Lung Cancer Product
Table 82. Merck Revenue in Lung Cancer Business (2016-2021) & (US$ Million)
Table 83. Merck Recent Development
Table 84. Bristol-Myers Squibb Company Details
Table 85. Bristol-Myers Squibb Business Overview
Table 86. Bristol-Myers Squibb Lung Cancer Product
Table 87. Bristol-Myers Squibb Revenue in Lung Cancer Business (2016-2021) & (US$ Million)
Table 88. Bristol-Myers Squibb Recent Development
Table 89. Eli Lilly And Company Company Details
Table 90. Eli Lilly And Company Business Overview
Table 91. Eli Lilly And Company Lung Cancer Product
Table 92. Eli Lilly And Company Revenue in Lung Cancer Business (2016-2021) & (US$ Million)
Table 93. Eli Lilly And Company Recent Development
Table 94. Sanof Company Details
Table 95. Sanof Business Overview
Table 96. Sanof Lung Cancer Product
Table 97. Sanof Revenue in Lung Cancer Business (2016-2021) & (US$ Million)
Table 98. Sanof Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Chemotherapy Features
Figure 4. Radiotherapy Features
Figure 5. Photodynamic Therapy Features
Figure 6. Laser Therapy Features
Figure 7. Global Lung Cancer Market Share by Application: 2020 VS 2027
Figure 8. Hospital & Clinics Case Studies
Figure 9. Cancer Research Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Lung Cancer Report Years Considered
Figure 12. Global Lung Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Lung Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Lung Cancer Market Share by Regions: 2020 VS 2027
Figure 15. Global Lung Cancer Market Share by Regions (2022-2027)
Figure 16. Global Lung Cancer Market Share by Players in 2020
Figure 17. Global Top Lung Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Lung Cancer Revenue in 2020
Figure 19. Global Lung Cancer Revenue Market Share by Type (2016-2021)
Figure 20. Global Lung Cancer Revenue Market Share by Type (2022-2027)
Figure 21. North America Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Lung Cancer Market Share by Type (2016-2027)
Figure 23. North America Lung Cancer Market Share by Application (2016-2027)
Figure 24. North America Lung Cancer Market Share by Country (2016-2027)
Figure 25. United States Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Lung Cancer Market Share by Type (2016-2027)
Figure 29. Europe Lung Cancer Market Share by Application (2016-2027)
Figure 30. Europe Lung Cancer Market Share by Country (2016-2027)
Figure 31. Germany Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Lung Cancer Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Lung Cancer Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Lung Cancer Market Share by Region (2016-2027)
Figure 41. China Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Lung Cancer Market Share by Type (2016-2027)
Figure 49. Latin America Lung Cancer Market Share by Application (2016-2027)
Figure 50. Latin America Lung Cancer Market Share by Country (2016-2027)
Figure 51. Mexico Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Lung Cancer Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Lung Cancer Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Lung Cancer Market Share by Country (2016-2027)
Figure 57. Turkey Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Lung Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Roche Revenue Growth Rate in Lung Cancer Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Lung Cancer Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Lung Cancer Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Lung Cancer Business (2016-2021)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Lung Cancer Business (2016-2021)
Figure 65. Eli Lilly And Company Revenue Growth Rate in Lung Cancer Business (2016-2021)
Figure 66. Sanof Revenue Growth Rate in Lung Cancer Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の肺がん手術市場規模・現状・予測（2021年-2027年） Lung adenocarcinoma is a type of lung cancer and belongs to non-small cell carcinoma. North America dominates the global lung cancer surgery market. Growth in the North American segment is primarily driven by the rapid growth in the aging population, availability of reimbursement for lung cancer sur…- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
- 世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung Cancer Treatment Drugs are durgs used to cure lung cancer. In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing…
- 世界の肺がん用リキッドバイオプシー市場規模・現状・予測（2021年-2027年） Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer. CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time. Market Analysis and Insigh…